Abstract
In this symposium we have been treated to a smorgasbord of progress in the subject area defined as “hormonal carcinogenesis.” Each speaker, an expert in his field, has presented his most recent achievements and in varying degrees has also laid out his own particular interpretation or perspective as to where we are going from here. It has been an exciting experience—and I am sure that the future will be even more provocative and productive. In fact, with respect to my particular assignment— “Future Perspectives on Hormonal Carcinogenesis” much of the turf has already been covered in the specialized topic areas. However, I shall take it as my responsibility to speak a bit panoramically—providing a cell biological framework that, hopefully, will be useful in interpreting ongoing experiments and making productive choices among the many future directions that are currently possible or are likely to soon arise. In particular, I shall try to point out some areas of cell and molecular biology where new knowledge is greatly needed if we are to reap the ultimate benefits from research in the field of hormonal carcinogenesis—a route to the prevention of these types of cancer or the development of an effective therapy for dealing with the human disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fearson ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759–767.
Lewin B (1991) Oncogenic conversion by regulatory changes in transcription factors. Cell 64: 303–312.
Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S (1991) Oncogenes and signal transduction. Cell 64: 281–302.
Friedman PN, Kern SE, Vogelstein B, and Prives C (1990) Wild-type, but mutant, human p53 proteins inhibit replicative activities of simian virus 40 large tumor antigen. Proc Natl Acad Sci USA 87: 9275–9279.
Hu Q, Dyson, Harlow E (1990) The regions of the retinoblastoma protein needed for binding to adeno E1A or SV40 large T antigen are common sites for mutation. EMBO J 9: 1147–1155.
Ludlow JW, Shon J, Pipas JM, Livingston DM, and DeCaprio JA (1990) The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60: 387–396.
Offringa R, Gebel S, Dam HV, Timmer M, Smits A, Zwart R, Stein B, Bos JL, Eb AV, Herrlick P (1990) A novel function of the transforming domaine of Ela: repression of AP-2D1 activity. Cell 62: 527–538.
Huang S, Lee WH, Lee EYHP (1991) A cellular protein that competes with SV40 T antigen for binding to retinoblastoma gene product. Nature.
Schuh TJ, Mueller GC (1991) Use of photo-crosslinking to demonstrate receptor-dependent, ligand modulated assembly of multi-protein complexes on the rat prolactin gene. (Manuscript submitted)
Lewin B (1990) Driving the cell cycle: M phase kinase, its partners and substrates. Cell 61: 743–752.
Lo SH, Aft R, Mueller GC (1981) Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells. Cancer Res 41: 864–870.
McBain JA, Pettit GR, Mueller GC (1990) Phorbol esters activate proteoglycan metabolism in human colon cancer cells en route to terminal differentiation. Cell Growth Different. 1: 281–291.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag New York, Inc.
About this paper
Cite this paper
Mueller, G.C. (1992). Hormonal Carcinogenesis—Future Perspectives. In: Li, J.J., Nandi, S., Li, S.A. (eds) Hormonal Carcinogenesis. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9208-8_30
Download citation
DOI: https://doi.org/10.1007/978-1-4613-9208-8_30
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-9210-1
Online ISBN: 978-1-4613-9208-8
eBook Packages: Springer Book Archive